National Institute for Occupational Safety and Health (NIOSH), Safety and Occupational Health Study Section (SOHSS); Notice of Meeting, 3399 [E7-1083]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 16 / Thursday, January 25, 2007 / Notices
findings for potential residual beryllium
contamination. Appendix B–3 describes
each facility evaluated for residual
beryllium contamination, the data
reviewed as a part of this evaluation,
and the final findings.
V. Conclusions
The findings of this study are: (1)
Some atomic weapons employer
facilities and beryllium vendor facilities
have the potential for significant
residual radiological and beryllium
contamination outside of the periods in
which weapons-related production
occurred. (2) For the purposes of this
report, NIOSH believes that facilities
having ‘‘significant contamination’’ had
quantities of radioactive material that
‘‘could have caused or substantially
contributed to the cancer of a covered
employee with cancer.’’ (3) The
documents reviewed did not indicate
the existence of a current, unrecognized
occupational or public health threat.
[FR Doc. E7–1157 Filed 1–24–07; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Information (RFI):
Guidance for Prioritization of Prepandemic and Pandemic Influenza
Vaccine—Extension of Comment
Period
Dated: January 19, 2007.
John O. Agwunobi,
Assistant Secretary of Health, Office of Public
Health and Science, Department of Health
and Human Services.
[FR Doc. 07–323 Filed 1–24–07; 8:45 am]
Office of the Secretary,
Department of Health and Human
Service.
AGENCY:
ACTION:
Notice.
On December 14, 2006, the
Department of Health and Human
Services (HHS) issued a notice in the
Federal Register (FR Doc. Vol. 71, No.
240, Pages 75252–75253) to request
input from the public on considerations
in developing guidance for
prioritization of the distribution and
administration of both pre-pandemic
and pandemic influenza vaccines based
on various pandemic severity and
vaccine supply scenarios. Specifically,
HHS is seeking input on pandemic
influenza vaccine prioritization
considerations from all interested and
affected parties, including but not
limited to public health and health care
individuals and organizations, as well
as those from other sectors of the
economy including, for example, travel
and transportation, commerce and trade,
law enforcement, emergency
management and responders, other
critical infrastructure sectors and the
general public.
ycherry on PROD1PC64 with NOTICES
SUMMARY:
VerDate Aug<31>2005
14:58 Jan 24, 2007
Jkt 211001
Previous reports relating to pandemic
influenza vaccine prioritization issues
are available at https://
www.pandemicflu.gov.
The purpose of this notice is to inform
all interested parties that the comment
period originally identified in the
December 14, 2006 Federal Register is
now being extended to February 5,
2007.
DATES: Responses should be submitted
to the Department of Health and Human
Services on or before 5 p.m., EDT,
February 5, 2007.
Instructions for Submitting
Comments: Electronic responses are
preferred and may be addressed to
PandemicFlu.RFI@hhs.gov. Written
responses should be addressed to the
Department of Health and Human
Services, Room 434E, 200 Independence
Avenue, SW., Washington, DC 20201,
Attention: Pandemic Influenza Vaccine
Prioritization RFI. A copy of this RFI is
also available on the PandemicFlu.Gov
Web site and at https://
www.aspe.hhs.gov/PIV/rfi. Please follow
instructions for submitting responses.
FOR FURTHER INFORMATION CONTACT: Ben
Schwartz, Office of Public Health and
Science, (404) 639–8953.
SUPPLEMENTARY INFORMATION: Extensive
information on Federal government
strategic and implementation plans for
pandemic flu is available at https://
www.pandemicflu.gov.
BILLING CODE 4151–05–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health (NIOSH), Safety and
Occupational Health Study Section
(SOHSS); Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned
committee meeting.
Times and Dates: 8 a.m.–5 p.m., February
20, 2007. 8 a.m.–5 p.m., February 21, 2007.
Place: Embassy Suites Hotel, 1900
Diagonal Road, Alexandria, Virginia, 22314,
telephone 703.684.5900, fax 703.684.1403.
Status: Open 8 a.m.–8:30 a.m., February
20, 2007. Closed 8:30 a.m.–5 p.m., February
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
3399
20, 2007. Closed 8 a.m.–5 p.m., February 21,
2007.
Purpose: The Safety and Occupational
Health Study Section will review, discuss,
and evaluate grant applications received in
response to the Institute’s standard grants
review and funding cycles pertaining to
research issues in occupational safety and
health and allied areas.
It is the intent of NIOSH to support broadbased research endeavors in keeping with the
Institute’s program goals. This will lead to
improved understanding and appreciation for
the magnitude of the aggregate health burden
associated with occupational injuries and
illnesses, as well as to support more focused
research projects, which will lead to
improvements in the delivery of occupational
safety and health services and the prevention
of work-related injury and illness. It is
anticipated that the research funded will
promote these program goals.
Matters to be Discussed: The meeting will
convene an open session from 8–8:30 a.m. on
February 20, 2007, to address matters related
to the conduct of SOHSS business. The
remainder of the meeting will proceed in
closed session. The purpose of the closed
session is for the study section to consider
safety and occupational health-related grant
applications. These portions of the meeting
will be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the
Determination of the Director, Management
Analysis and Services Office, Centers for
Disease Control and Prevention, pursuant to
Section 10(d) Pub. L. 92–463. Agenda items
are subject to change as priorities dictate.
For Further Information Contact: Price
Connor, Ph.D., NIOSH Health Scientist, 1600
Clifton Road, NE., Mailstop E–20, Atlanta,
Georgia 30333, telephone 404.498.2511, fax
404.498.2571.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–1083 Filed 1–24–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 72, Number 16 (Thursday, January 25, 2007)]
[Notices]
[Page 3399]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-1083]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH),
Safety and Occupational Health Study Section (SOHSS); Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned committee meeting.
Times and Dates: 8 a.m.-5 p.m., February 20, 2007. 8 a.m.-5
p.m., February 21, 2007.
Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria,
Virginia, 22314, telephone 703.684.5900, fax 703.684.1403.
Status: Open 8 a.m.-8:30 a.m., February 20, 2007. Closed 8:30
a.m.-5 p.m., February 20, 2007. Closed 8 a.m.-5 p.m., February 21,
2007.
Purpose: The Safety and Occupational Health Study Section will
review, discuss, and evaluate grant applications received in
response to the Institute's standard grants review and funding
cycles pertaining to research issues in occupational safety and
health and allied areas.
It is the intent of NIOSH to support broad-based research
endeavors in keeping with the Institute's program goals. This will
lead to improved understanding and appreciation for the magnitude of
the aggregate health burden associated with occupational injuries
and illnesses, as well as to support more focused research projects,
which will lead to improvements in the delivery of occupational
safety and health services and the prevention of work-related injury
and illness. It is anticipated that the research funded will promote
these program goals.
Matters to be Discussed: The meeting will convene an open
session from 8-8:30 a.m. on February 20, 2007, to address matters
related to the conduct of SOHSS business. The remainder of the
meeting will proceed in closed session. The purpose of the closed
session is for the study section to consider safety and occupational
health-related grant applications. These portions of the meeting
will be closed to the public in accordance with provisions set forth
in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination
of the Director, Management Analysis and Services Office, Centers
for Disease Control and Prevention, pursuant to Section 10(d) Pub.
L. 92-463. Agenda items are subject to change as priorities dictate.
For Further Information Contact: Price Connor, Ph.D., NIOSH
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta,
Georgia 30333, telephone 404.498.2511, fax 404.498.2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-1083 Filed 1-24-07; 8:45 am]
BILLING CODE 4163-18-P
